Potential role of novel hepatocellular carcinoma-associated gene IDD01 in promoting tumorigenesis of HepG2 cell line

Chinese Medical Journal

Volumn 119, Issue 20, 2006, Pages 1709-1714

  Chen, Xiang Yu ^a   Li, Jian Sheng ^a   Ma, Jun ^a   Duan, Fang Ling ^a   Zhong, Peng ^b  

^a ZHENGZHOU UNIVERSITY   (China)

^b JILIN UNIVERSITY   (China)

Author keywords

Gene expression; Hepatocellular carcinoma; IDD01 gene; Plasmids

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CELL PROTEIN; COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; LIPOFECTAMINE; MESSENGER RNA; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PROTEIN IDD01; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE; UNCLASSIFIED DRUG;

AGAR MEDIUM; ARTICLE; BIOINFORMATICS; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL STRAIN HEPG2; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; COLORIMETRY; CONTROLLED STUDY; DNA LIBRARY; EFFECTOR CELL; EXPRESSED SEQUENCE TAG; FLOW CYTOMETRY; GENE TRANSFER; GENETIC TRANSFECTION; HISTOGRAM; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PROTEIN FUNCTION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; RECOMBINANT PLASMID; RESTRICTION MAPPING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBTRACTIVE HYBRIDIZATION;

EID: 33750698585     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200610020-00007     Document Type: Article

References (24)

1. Xiao E, Li D, Shen S, Zhou S, Zhou S, Tan L, et al. Effect of preoperative transcatheter arterial chemoembolization on apoptosis of hepatocellular carcinoma cells. Chin Med J 2003; 116: 203-207.
2. Lu DD, Zhang XR, Cao XR. Expression of TN4 gene and its role in human hepatocarcinogenesis from Qidong, a liver cancer risk area. Chin Med J 2004; 117: 440-444.
3. Li GC, Yang JM, Nie MM, Su CG, Sun LC, Qian YZ, et al. Potent antitumoral effects of a novel gene-viral therapeutic system CNHK300-mEndostatin in hepatocellular carcinoma. Chin Med J 2005; 118: 179-185.
4. Zhu WL, Duan FL, Liu DL, Fan BL, Zhang L, Gao TH, et al. Cloning the genes differently expressed in human hepatocellular carcinoma by suppression subtractive hybridization. Chin J Hepatol (Chin) 2003; 11: 183-184.
5. Chen XY, Duan FL, Li JS, Zhu WL, Han ZG, Li YL, et al. Analysis and function prediction of ESTs differentially expressed in HCC by Bioinformatics strategy. Chin J Gastro Hepatol (Chin) 2004; 13: 43-48.
6. Chen XY, Li JS, Duan FL, Li YL, Ma J, Xue LX, et al. Cloning and identification of a candidate novel gene IDD01 associated with hepatocellular carcinoma. J Zhengzhou Univ (Chin) 2004; 39: 413-415.
7. Chen XY, Duan FL, Li JS, Ma J, Xue LX. Construction and expression of prokaryotic vector of a novel candidate gene IDD01 associated with hepatocellular carcinoma. Acta Academiae Medicinae Militaris Tertiae 2004; 26: 892-894.
8. Brechot C. Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. Gastroenterology 2004; 127: s56-s61.
9. Liang TJ, Heller T. Pathogenesis of hepatitis C-associated hepatocellular carcinoma. Gastroenterology 2004; 127: s62-s71.
10. Poon RT, Fan ST. Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome. Liver Transpl 2004; 10: s39-s45.
11. Varela M, Sala M, Llovet JM, Bruix J. Treatment of hepatocellular carcinoma: is there an optimal strategy? Cancer Treat Rev 2003; 29: 99-104.
12. Paterlini-Brechot P, Saigo K, Murakami Y, Chami M, Gozuacik D, Mugnier C, et al. Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene. Oncogene 2003; 22: 3911-3916.
13. Yang DH, Huang W, Cui J, Shu JC, Tang SH, Zhang WJ, et al. The relationship between point mutation and abnormal expression of c-fms oncogene in hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2004; 3: 86-89.
14. Suzuki S, Kondo Y, Hirashima N, Kato H, Sugauchi F, Tanaka Y, et al. Evaluation of loss of heterozygosity before and after interferon therapy in patients with hepatitis C virus infection who developed hepatocellular carcinoma during follow up. J Gastroenterol Hepatol 2003; 18: 1364-1372.
15. Moinzadeh P, Breuhahn K, Stutzer H, Schirmacher P. Chromosome alterations in human hepatocellular carcinomas correlate with aetiology and histological grade-results of an explorative CGH meta-analysis. Br J Cancer 2005; 92: 935-941.
16. Kim GJ, Cho SJ, Won NH, Sung JM, Kim H, Chun YH, et al. Genomic imbalances in Korean hepatocellular carcinoma. Cancer Genet Cytogenet 2003; 142: 129-133.
17. Harada N, Oshima H, Katoh M, Tamai Y, Oshima M, Taketo MM. Hepatocarcinogenesis in mice with beta-catenin and Ha-ras gene mutations. Cancer Res 2004; 64: 48-54.
18. Yao X, Hu JF, Daniels M, Yien H, Lu H, Sharan H, et al. A novel orthotopic tumor model to study growth factors and oncogenes in hepatocarcinogenesis. Clin Cancer Res 2003; 9: 2719-2726.
19. Kim JH, Rho HM. Activation of the human transforming growth factor alpha (TGF-alpha) gene by the hepatitis B viral X protein (HBx) through AP-2 sites. Mol Cell Biochem 2002; 231: 155-161.
20. Chan CF, Yau TO, Jin DY, Wong CM, Fan ST, Ng IO. Evaluation of nuclear factor-kappa B, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma. Clin Cancer Res 2004; 10: 4140-4149.
21. Lee JS, Thorgeirsson SS. Genome-scale profiling of gene expression in hepatocellular carcinoma: classification, survival prediction, and identification of therapeutic targets. Gastroenterology 2004; 127: s51-s55.
22. Bucca G, Carruba G, Saetta A, Muti P, Castagnetta L, Smith CP. Gene expression profiling of human cancers. Ann N Y Acad Sci 2004; 1028: 28-37.
23. Duffy MJ. Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? Clin Chem 2001; 47: 624-630.
24. Johnson PJ. The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma. Clin Liver Dis 2001; 5: 145-159.